John Paul Mathias

Person

Concord, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 12,202,836
- Issue date Jan 21, 2025
- Pfizer Inc.
- John David Trzupek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 11,702,424
- Issue date Jul 18, 2023
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 10,793,579
- Issue date Oct 6, 2020
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,766,904
- Issue date Sep 8, 2020
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidines as CFTR potentiators
- Patent number 10,494,374
- Issue date Dec 3, 2019
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,377,762
- Issue date Aug 13, 2019
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 10,329,302
- Issue date Jun 25, 2019
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
- Patent number 10,316,018
- Issue date Jun 11, 2019
- Pfizer Inc.
- Katherine Lin Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as inhibitors of Vanin-1 enzyme
- Patent number 10,308,615
- Issue date Jun 4, 2019
- Pfizer Inc.
- Agustin Casimiro-Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidines as CFTR potentiators
- Patent number 10,301,315
- Issue date May 28, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,208,053
- Issue date Feb 19, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
- Patent number 10,174,000
- Issue date Jan 8, 2019
- Pfizer Inc.
- Katherine Lin Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,131,670
- Issue date Nov 20, 2018
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 9,879,022
- Issue date Jan 30, 2018
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 9,458,168
- Issue date Oct 4, 2016
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20230339960
- Publication date Oct 26, 2023
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrrolopyrimidines as CFTR Potentiators
- Publication number 20230250100
- Publication date Aug 10, 2023
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrrolopyrimidines as CFTR Potentiators
- Publication number 20210171534
- Publication date Jun 10, 2021
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20200377511
- Publication date Dec 3, 2020
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINES AS CFTR POTENTIATORS
- Publication number 20200017512
- Publication date Jan 16, 2020
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20190330219
- Publication date Oct 31, 2019
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME
- Publication number 20190292157
- Publication date Sep 26, 2019
- Pfizer Inc.
- Agustin Casimiro-Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20190270751
- Publication date Sep 5, 2019
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINES AS CFTR POTENTIATORS
- Publication number 20190225621
- Publication date Jul 25, 2019
- CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS
- Publication number 20190092750
- Publication date Mar 28, 2019
- Pfizer Inc.
- KATHERINE LIN LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20190016727
- Publication date Jan 17, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20190016728
- Publication date Jan 17, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS
- Publication number 20180244646
- Publication date Aug 30, 2018
- Pfizer Inc.
- KATHERINE LIN LEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20180170938
- Publication date Jun 21, 2018
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME
- Publication number 20180148420
- Publication date May 31, 2018
- Pfizer Inc.
- Agustin Casimiro-Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINES AS CFTR POTENTIATORS
- Publication number 20180141954
- Publication date May 24, 2018
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20180127432
- Publication date May 10, 2018
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20160347760
- Publication date Dec 1, 2016
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20150284405
- Publication date Oct 8, 2015
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

John Paul Mathias

Person

Patents Grantslast 30 patents

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic heteroaryl derivatives as CFTR potentiators

Pyrrolopyrimidines as CFTR potentiators

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators

Heterocyclic compounds as inhibitors of Vanin-1 enzyme

Pyrrolopyrimidines as CFTR potentiators

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds

Patents Applicationslast 30 patents

Bicyclic-Fused Heteroaryl or Aryl Compounds

Pyrrolopyrimidines as CFTR Potentiators

Pyrrolopyrimidines as CFTR Potentiators

Bicyclic-Fused Heteroaryl or Aryl Compounds

PYRROLOPYRIMIDINES AS CFTR POTENTIATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME

Bicyclic-Fused Heteroaryl or Aryl Compounds

PYRROLOPYRIMIDINES AS CFTR POTENTIATORS

BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME

PYRROLOPYRIMIDINES AS CFTR POTENTIATORS

Bicyclic-Fused Heteroaryl or Aryl Compounds

Bicyclic-Fused Heteroaryl or Aryl Compounds

Bicyclic-Fused Heteroaryl or Aryl Compounds